Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
XETRA:DMP
Price:
33.5 EUR
4.36%
Market Closed
Updated:
May 4, 2024
Dermapharm Holding SE
Operating Income
|
Dermapharm Holding SE
Operating Income Peer Comparison
Comparables:
ATAI
BAYN
MRK
93M1
PSG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Operating Income
€201m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Operating Income
-$125.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Operating Income
€8.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
Merck KGaA
XETRA:MRK
|
Operating Income
€4.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Operating Income
-€975.1k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Operating Income
€17.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Dermapharm Holding SE's Operating Income?
Operating Income
201m
EUR
201m
EUR
Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Operating Income amounts to 201m EUR.
What is Dermapharm Holding SE's Operating Income growth rate?
Operating Income CAGR 5Y
12%
12%
Over the last year, the Operating Income growth was -29%. The average annual Operating Income growth rates for Dermapharm Holding SE have been 12% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
